Anthony Pompliano
CEO of Professional Capital Management, Podcast Host & Author
A tiny number of companies create most stock market wealth, so the job is to find them and hold on. Since 1925, 46 companies have delivered half of the $90 trillion of value created. The best investors press their winners harder, and diversifying signals a lack of conviction. Portfolio construction that combines uncorrelated assets, each with a chance at 10x or 100x, keeps volatility down while staying above average for decades. data-1.podcastai.comÂ
RoboStrategy gives retail investors pre-IPO exposure to leading US humanoid robot makers, and its chart is coiled for a breakout. CEO Andrew Kang named Tesla Optimus, Figure AI and Apptronik his top three American humanoid plays from 112 startups; Figure AI and Apptronik are among its largest disclosed holdings. He cited Figure 03 robots sorting a quarter-million packages over 200 hours without a major glitch. Price has squeezed into a symmetrical triangle since July, with $29.50 as the trigger. … Show more
RoboStrategy's portfolio is gaining real-world validation: its fourth- and fifth-largest holdings, Apptronik at 15% of NAV and Dexmate at 10%, are being used at Google. x.comÂ
BOT risks trapping retail buyers at large gaps to its NAV, since its shares trade daily on hype and social media noise, amplified by insiders with big reach on X, while its private robotics holdings sit at rarely updated funding-round valuations with no continuous market check. Its 2.5% management fee and 3.22% total expense ratio also set an exceptionally high bar for returns. x.comÂ
The biotech and genomics boom is best owned broadly, because single biotech stocks are binary bets on trial results no analyst can handicap. One failed readout can halve a stock, as Novo Nordisk's lost market value on disappointing data showed. Owning blue-chip biotech and high-beta genomics as diversified baskets captures the funding rebound, the AI drug-discovery tailwind and the re-rating after years of deep bear market and a decisive breakout, without the single-molecule lottery. x.com x.com … Show more
New investors who think they missed the AI run can still build exposure diversified across AI layers, chosen on today's valuations and risk-reward. A suggested split is 20% each in Meta, NVIDIA and Broadcom, and 10% each in a DRAM memory ETF, TSMC, Nebius and Credo: 80% in established leaders and critical bottlenecks, 20% in faster-growing compute and networking names. It spans applications, GPUs, custom silicon, foundries, memory, networking and cloud, and most picks are founder-led. x.com … Show more
RoboStrategy is a red flag because buyers pay about five times its net asset value, effectively valuing its Figure stake at over $200 billion versus Figure's $39 billion valuation. Shares trade at $37.92 against a NAV of $7.34, and about $2 billion of ongoing dilution exploits that gap. Most retail buyers don't read filings or understand closed-end funds, so the price reflects float dynamics, not fundamentals, leaving them as exit liquidity. Unitree, the top humanoid maker, lists at $6 billion. … Show more
Frontier tech stocks such as Nvidia, Tesla and SpaceX offer the biggest asymmetric upside in a generation, with at least ten years of explosive growth to be monetized through public markets rather than crypto. AI agents and infrastructure, the space economy, robotics and energy breakthroughs will accrue value to listed companies with real revenue and moats. SpaceX's record IPO raise is a case study, with Starship, Starlink and defense contracts ahead, as retail liquidity rotates into stocks. … Show more
A concentrated, equal-weight bet on the next cycle across four megatrends: AI infrastructure, digital finance, Ethereum and autonomous systems, held for two to three years. Meta and Palantir cover AI, SoFi and Robinhood digital finance, BitMine as the biggest ETH treasury on the market, and Tesla for its robotics and AI optionality. This is deliberately not a diversified index. x.comÂ
RoboStrategy's model breaks if it trades below 1x mNAV, so buying at 3.5x mNAV makes little sense. Below NAV it would have to sell holdings to buy back stock. A post the author replies to compares it to Berkshire and SoftBank, which traded at discounts for decades, but Berkshire grew capital through insurance float and SoftBank through its Vision Funds; neither relied on issuing shares above NAV. RoboStrategy can't grow capital unless retail pays more than $1 for $1 of illiquid assets. x.com … Show more
These specialized ETFs justify high expense ratios because they do things investors can't do themselves. Some hold pre-IPO companies such as SpaceX and Anthropic; others offer active management that has beaten the S&P 500 since inception, hedge-fund-style sub-advised alpha, risk-managed leverage, income without NAV decay or income with upside, exposure to stocks investors can't buy directly, or a broad diversified portfolio in one click. x.comÂ
